Scarica l'app Stockscreener
26.25
2.20%
-0.59
Dopo l'orario di chiusura:
26.24
-0.01
-0.04%
Liquidia Corp Borsa (LQDA) Ultime notizie
Court Victory and Fresh Funding Propel Growth at Liquidia Corporation - Yahoo Finance
Live Scanner Shows Breakout on Liquidia CorporationPortfolio Gains Summary & Low Risk Entry Point Guides - 한국정경신문
Jefferies initiates Liquidia stock with Buy rating, $43 price target - Investing.com
Jefferies initiates Liquidia stock with Buy rating, $43 price target By Investing.com - Investing.com UK
Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Liquidia Technologies stock hits 52-week high at 25.19 USD - Investing.com
Liquidia's Q2 Results Boost Analyst Forecasts, Shares Rise - AInvest
Liquidia's Yutrepia Prescriptions Soar, Shares Rise 13.68% - AInvest
Liquidia (LQDA) Climbs 13.68% as Yutrepia Prescriptions Surge - Insider Monkey
Liquidia stock price target raised to $49 from $40 at BTIG - Investing.com Canada
Liquidia (LQDA) Rating Maintained as Strong Buy by Raymond James - GuruFocus
Wells Fargo Raises Liquidia (LQDA) Price Target to $31 | LQDA St - GuruFocus
Liquidia Corporation (NASDAQ:LQDA) Q2 2025 Earnings Call Transcript - Insider Monkey
Liquidia: Raymond James maintains Strong Buy, raises PT to $41 from $33. - AInvest
Wells Fargo Raises Liquidia PT to $31 from $25, Maintains Overweight Rating - AInvest
Liquidia stock price target raised to $31 by Wells Fargo on strong launch - Investing.com Canada
Liquidia stock price target raised to $41 from $33 at Raymond James - Investing.com Nigeria
Liquidia: Needham Raises PT to $36 from $32, Maintains Buy Rating - AInvest
Liquidia 2025 Q2 Earnings Wider Losses Despite Revenue Surge - AInvest
Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YUTREPIA Launch and Financial Position - Yahoo Finance
Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YU - GuruFocus
Decoding Liquidia Corp (LQDA): A Strategic SWOT Insight - GuruFocus
10 Stocks on Euphoria. Are You Holding Any? - Insider Monkey
United Therapeutics Shares Rise 0.32% Amid Patent Dispute with Liquidia Trading Volume Ranked 420th in Market Activity - AInvest
Liquidia Corporation shares rise 15.19% intraday after reporting positive interim data from ASCENT trial. - AInvest
Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Liquidia Stock Surges as Q2 Earnings Beat Expectations - AInvest
Liquidia (LQDA): A High-Growth Biotech Play with Explosive Revenue Momentum and a Path to Profitability - AInvest
Liquidia's Q2 2025 Earnings Call: Unpacking Key Contradictions on YUTREPIA's Market Access and Data Presentation - AInvest
Liquidia Corporation Q2 2025 Earnings Call Transcript Analysis: Key Takeaways and Insights - AInvest
Liquidia Sees Boost in YUTREPIA Adoption, Aims for Expanded Market Access in H2 2025. - AInvest
When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - 富途牛牛
Earnings call transcript: Liquidia Q2 2025 sees revenue surge, stock jumps - Investing.com
Liquidia Q2 2025 slides: Yutrepia launch drives 141% revenue growth amid widening losses - Investing.com
Liquidia Corporation shares surge 13.44% in premarket after strong Q2 earnings and positive drug trial results. - AInvest
Liquidia Stock Soars 10.61% on Q2 Earnings - AInvest
Liquidia Technologies earnings missed by $0.07, revenue topped estimates - Investing.com
Liquidia Corp SEC 10-Q Report - TradingView
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update - TradingView
Liquidia Q2 2025 Earnings Preview: Key Estimates and Trends - AInvest
Earnings To Watch: Liquidia Corp (LQDA) Reports Q2 2025 Result - Yahoo Finance
Liquidia (LQDA): Navigating Legal Uncertainty and YUTREPIA's Launch to Unlock Hidden Value - AInvest
Liquidia: Uncertainty Has Always Been A Buying Opportunity (LQDA) - Seeking Alpha
Will Liquidia Corporation Sustain Its Chart BreakoutReversal Alert Based on RSI Indicator Confirmed - beatles.ru
Liquidia Corp expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Liquidia Corporation's Profit Outlook: A Comprehensive Analysis of the Biopharmaceutical Company's Future Prospects - AInvest
Liquidia Corporation's (NASDAQ:LQDA) Profit Outlook - Yahoo Finance
Liquidia Corp Announces Q2 2025 Earnings Release and Webcast - AInvest
Liquidia Technologies Experiences Promising Start with Yutrepia's Strong Launch - AInvest
Liquidia Technologies stock hits 52-week high at 20.33 USD - Investing.com
Liquidia Technologies stock hits 52-week high at 20.33 USD By Investing.com - Investing.com UK
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12 - Quiver Quantitative
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times
How does Liquidia Corporation generate profit in a changing economyConsistently outstanding ROI - Jammu Links News
What analysts say about Liquidia Corporation stockTremendous growth potential - Jammu Links News
Published on: 2025-08-03 22:16:43 - Jammu Links News
What makes Liquidia Corporation stock price move sharplyUnlock daily market insights for better trades - Jammu Links News
Why is Liquidia Corporation stock attracting strong analyst attentionMarket-leading profit generation - Jammu Links News
Chart Analysts Warn of Resistance Near Liquidia Corporation PriceEarly Entry Picks Before News Breakout Reviewed - metal.it
BTIG Lowers Liquidia (LQDA) PT to $40, Potential for Yutrepia Launch Remains a Focus - MSN
Liquidia Corporation shares rise 1.75% after-hours following United Therapeutics' $1 billion accelerated share repurchase program. - AInvest
Will Liquidia Corporation bounce back from current supportWeekly Return Plan for Conservative Traders - Newser
1.38%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):